GL-1196 and LC-0882 are both small-molecule inhibitors of PAK4, both of which inhibit the phosphorylation of PAK4, and inhibit the G1/S transition of the gastric cancer cells by downregulating Cyclin D1. Here, PAK4 is linked to gastric cancer.